Brainsway Ltd. (BWAY)

Evaluation: Based on all recent filings, financial statements, and news.

See full evaluation
Ask a question about Brainsway Ltd. (BWAY)
Company Performance

Current Price

as of Oct 16, 2024

$9.60

P/E Ratio

263.01

Market Cap

$156.99M

Description

Brainsway Ltd. engages in the development and sale of non-invasive neurostimulation treatments using the proprietary Deep Transcranial Magnetic Stimulation (Deep TMS) technology for the treatment of major depressive disorder (MDD) and obsessive-compulsive disorder (OCD). The Deep TMS uses magnetic pulses to stimulate neurons and consequently modulates the physiological activity of the brain. The company was founded by Avner Hagai, Yiftach Roth, Abraham Zangen, and David Zacut on November 7, 2006 and is headquartered in Jerusalem, Israel.

Metrics

Overview

  • HQJerusalem, JM
  • SectorHealth Technology
  • IndustryMedical Specialties
  • TickerBWAY
  • Price$9.6+3.00%

Trading Information

  • Market Cap$156.99M
  • Float100.00%
  • Average Daily Volume (1m)113,359
  • Average Daily Volume (3m)100,389
  • EPS$0.04

Company

  • Revenue$36.43M
  • Rev Growth (1yr)27.79%
  • Net Income$0.60M
  • Gross Margin75.33%
  • EBITDA Margin8.84%
  • EBITDA$0.88M
  • EV$57.39M
  • EV/Revenue1.58
  • P/E263.01
  • P/S4.39
  • P/B3.80